Cite
HARVARD Citation
Menzies-Gow, A. et al. (2023). Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study. Lancet. 11 (5), pp. 425-438. [Online].